Global Entericoated Tablets Market is expected to grow at a CAGR of XX% during the forecast period. The market is driven by factors such as increasing prevalence of gastrointestinal disorders, rising awareness about the benefits of enteric coated tablets, and growing demand for over-the-counter drugs. However, high cost associated with enteric coated tablets may hamper the growth of this market.
The global entericoated tablets market has been segmented on the basis of type (aspirin, serrapeptase, bisacodyl, esomeprazole magnesium, pantoprazole sodium), application (hospital and clinic) and region (North America, Latin America, Europe Asia Pacific and Middle East & Africa). North America accounted for a major share in the global entericoated tablets market in 2017 owing to high adoption rates among consumers. Asia Pacific is expected to witness significant growth during the forecast period due to increasing awareness about gastrointestinal disorders in emerging economies such as India and China.
-The global Enteric-coated Tablets market is expected to grow at a CAGR of 4.5% during the forecast period, 2018-2025.
-The global Enteric-coated Tablets market is driven by factors such as increasing prevalence of gastrointestinal disorders and rising demand for enteric coated tablets in emerging economies.
-Increasing prevalence of gastrointestinal disorders such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) are driving the growth of the global Enteric-coated Tablets market.
-Rising demand for enteric coated tablets in emerging economies such as India, China, Brazil, and Mexico is also driving the growth of the global Enteric Coated Tablet Market.
Industry Growth Insights published a new data on “Enteric-coated Tablets Market”. The research report is titled “Enteric-coated Tablets Market research by Types (Aspirin, Serrapeptase, Bisacodyl, Esomeprazole Magnesium, Pantoprazole Sodium, Mycophenolate Sodium, Paroxetine Hydrochloride), By Applications (Hospital, Clinic), By Players/Companies Bayer, Weidar Chemical & Pharmaceutical, AstraZeneca, Boehringer Ingelheim, Takeda, Novartis, Dr.Reddy`s, GSK”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Enteric-coated Tablets Market Research Report
By Type
Aspirin, Serrapeptase, Bisacodyl, Esomeprazole Magnesium, Pantoprazole Sodium, Mycophenolate Sodium, Paroxetine Hydrochloride
By Application
Hospital, Clinic
By Companies
Bayer, Weidar Chemical & Pharmaceutical, AstraZeneca, Boehringer Ingelheim, Takeda, Novartis, Dr.Reddy`s, GSK
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Enteric-coated Tablets Market Report Segments:
The global Enteric-coated Tablets market is segmented on the basis of:
Types
Aspirin, Serrapeptase, Bisacodyl, Esomeprazole Magnesium, Pantoprazole Sodium, Mycophenolate Sodium, Paroxetine Hydrochloride
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer
- Weidar Chemical & Pharmaceutical
- AstraZeneca
- Boehringer Ingelheim
- Takeda
- Novartis
- Dr.Reddy`s
- GSK
Highlights of The Enteric-coated Tablets Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Aspirin
- Serrapeptase
- Bisacodyl
- Esomeprazole Magnesium
- Pantoprazole Sodium
- Mycophenolate Sodium
- Paroxetine Hydrochloride
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Enteric-coated Tablets Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Enteric-coated tablets are a type of medication that is coated in an enteric coating to protect it from being broken down by the stomach and intestines. This makes them less likely to cause side effects, such as diarrhea, when they are taken by mouth.
Some of the major players in the enteric-coated tablets market are Bayer, Weidar Chemical & Pharmaceutical, AstraZeneca, Boehringer Ingelheim, Takeda, Novartis, Dr.Reddy`s, GSK.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Enteric-coated Tablets Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Enteric-coated Tablets Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Enteric-coated Tablets Market - Supply Chain
4.5. Global Enteric-coated Tablets Market Forecast
4.5.1. Enteric-coated Tablets Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Enteric-coated Tablets Market Size (000 Units) and Y-o-Y Growth
4.5.3. Enteric-coated Tablets Market Absolute $ Opportunity
5. Global Enteric-coated Tablets Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Enteric-coated Tablets Market Size and Volume Forecast by Type
5.3.1. Aspirin
5.3.2. Serrapeptase
5.3.3. Bisacodyl
5.3.4. Esomeprazole Magnesium
5.3.5. Pantoprazole Sodium
5.3.6. Mycophenolate Sodium
5.3.7. Paroxetine Hydrochloride
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Enteric-coated Tablets Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Enteric-coated Tablets Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinic
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Enteric-coated Tablets Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Enteric-coated Tablets Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Enteric-coated Tablets Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Enteric-coated Tablets Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Enteric-coated Tablets Demand Share Forecast, 2019-2026
9. North America Enteric-coated Tablets Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Enteric-coated Tablets Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Enteric-coated Tablets Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinic
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Enteric-coated Tablets Market Size and Volume Forecast by Type
9.7.1. Aspirin
9.7.2. Serrapeptase
9.7.3. Bisacodyl
9.7.4. Esomeprazole Magnesium
9.7.5. Pantoprazole Sodium
9.7.6. Mycophenolate Sodium
9.7.7. Paroxetine Hydrochloride
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Enteric-coated Tablets Demand Share Forecast, 2019-2026
10. Latin America Enteric-coated Tablets Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Enteric-coated Tablets Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Enteric-coated Tablets Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinic
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Enteric-coated Tablets Market Size and Volume Forecast by Type
10.7.1. Aspirin
10.7.2. Serrapeptase
10.7.3. Bisacodyl
10.7.4. Esomeprazole Magnesium
10.7.5. Pantoprazole Sodium
10.7.6. Mycophenolate Sodium
10.7.7. Paroxetine Hydrochloride
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Enteric-coated Tablets Demand Share Forecast, 2019-2026
11. Europe Enteric-coated Tablets Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Enteric-coated Tablets Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Enteric-coated Tablets Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinic
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Enteric-coated Tablets Market Size and Volume Forecast by Type
11.7.1. Aspirin
11.7.2. Serrapeptase
11.7.3. Bisacodyl
11.7.4. Esomeprazole Magnesium
11.7.5. Pantoprazole Sodium
11.7.6. Mycophenolate Sodium
11.7.7. Paroxetine Hydrochloride
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Enteric-coated Tablets Demand Share, 2019-2026
12. Asia Pacific Enteric-coated Tablets Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Enteric-coated Tablets Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Enteric-coated Tablets Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinic
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Enteric-coated Tablets Market Size and Volume Forecast by Type
12.7.1. Aspirin
12.7.2. Serrapeptase
12.7.3. Bisacodyl
12.7.4. Esomeprazole Magnesium
12.7.5. Pantoprazole Sodium
12.7.6. Mycophenolate Sodium
12.7.7. Paroxetine Hydrochloride
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Enteric-coated Tablets Demand Share, 2019-2026
13. Middle East & Africa Enteric-coated Tablets Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Enteric-coated Tablets Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Enteric-coated Tablets Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinic
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Enteric-coated Tablets Market Size and Volume Forecast by Type
13.7.1. Aspirin
13.7.2. Serrapeptase
13.7.3. Bisacodyl
13.7.4. Esomeprazole Magnesium
13.7.5. Pantoprazole Sodium
13.7.6. Mycophenolate Sodium
13.7.7. Paroxetine Hydrochloride
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Enteric-coated Tablets Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Enteric-coated Tablets Market: Market Share Analysis
14.2. Enteric-coated Tablets Distributors and Customers
14.3. Enteric-coated Tablets Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Bayer
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Weidar Chemical & Pharmaceutical
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. AstraZeneca
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Boehringer Ingelheim
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Takeda
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Novartis
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Dr.Reddy`s
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. GSK
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
